close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

Home・Aandelen Lijst・MiNK Therapeutics
Search

MiNK Therapeutics

Gesloten

11.31 -6.99

Buy

Prijsupdate 5 dec 2025, 20:58 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

11.04

Max

11.75

Belangrijke statistieken

By Trading Economics

Inkomsten

1.4M

-2.9M

EPS

-0.65

Winstmarge

-0.065

Werknemers

23

EBITDA

1.3M

-2.8M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+204.35% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-10M

52M

Vorige openingsprijs

18.3

Vorige sluitingsprijs

11.31

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

7.81 / 8.1 Steun & Weerstand

MiNK Therapeutics Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 dec 2025, 21:08 UTC

Acquisities, Fusies, Overnames

Meta Platforms Buys AI-Device Maker Limitless

DJ

Lezen

5 dec 2025, 19:39 UTC

Belangrijke Marktbewegers

Parsons' FAA Bid Loss Clouds Outlook After Rocky Year for Contractors

DJ

Lezen

5 dec 2025, 19:17 UTC

Acquisities, Fusies, Overnames

Constellation Energy Agrees to Divest Assets to Finalize Calpine Deal

DJ

Lezen

6 dec 2025, 16:52 UTC

Acquisities, Fusies, Overnames

As Netflix Swoops In to Buy Warner Bros., We Revisit the Studio's Long, Twisted Journey -- Barrons.com

DJ

Lezen

6 dec 2025, 10:30 UTC

Winsten
Acquisities, Fusies, Overnames

Why Netflix Shareholders Aren't Thrilled to Acquire Warner Bros. -- Heard on the Street -- WSJ

DJ

Lezen

6 dec 2025, 02:38 UTC

Acquisities, Fusies, Overnames

How a Netflix-Warner Deal Would Change Everything in Hollywood -- Again -- WSJ

DJ

Lezen

5 dec 2025, 21:59 UTC

Acquisities, Fusies, Overnames

Netflix's Megadeal Will Need the Trump Administration's Blessing -- Update

DJ

Lezen

5 dec 2025, 21:50 UTC

Marktinformatie
Winsten

Financial Services Roundup: Market Talk

DJ

Lezen

5 dec 2025, 21:50 UTC

Acquisities, Fusies, Overnames

The Netflix and Warner Bros. Deal Is Far From a Sure Thing -- Barrons.com

DJ

Lezen

5 dec 2025, 21:36 UTC

Marktinformatie

Return of Shipping to Red Sea a Step Closer, Xeneta Says -- Market Talk

DJ

Lezen

5 dec 2025, 21:35 UTC

Acquisities, Fusies, Overnames

The Netflix-Warner Bros. Deal Has a Wildcard. How Paramount Could Still Win. -- Barrons.com

DJ

Lezen

5 dec 2025, 21:26 UTC

Acquisities, Fusies, Overnames

Warner Bros. Discovery and Netflix Enter Exclusive Deal Negotiations -- 7th Update

DJ

Lezen

5 dec 2025, 21:12 UTC

Marktinformatie

Natural Gas Surge 9% This Week on Strong Flow of Exports -- Market Talk

DJ

Lezen

5 dec 2025, 21:03 UTC

Marktinformatie
Winsten

Bank of Montreal Logs Solid Quarter, Though Some Unease Remains -- Market Talk

DJ

Lezen

5 dec 2025, 21:01 UTC

Marktinformatie

Oil Caps Positive Week on Geopolitical Turmoil -- Market Talk

DJ

Lezen

5 dec 2025, 20:43 UTC

Acquisities, Fusies, Overnames

Limitless CEO Siroker: Will No Longer Sell Pendant to New Customers

DJ

Lezen

5 dec 2025, 20:43 UTC

Acquisities, Fusies, Overnames

Limitless CEO Siroker: Existing Pendant Customers to Be Supported for at Least Another Year

DJ

Lezen

5 dec 2025, 20:42 UTC

Acquisities, Fusies, Overnames

Limitless CEO Dan Siroker: Limitless Has Been Acquired by Meta >META

DJ

Lezen

5 dec 2025, 20:01 UTC

Acquisities, Fusies, Overnames

Netflix Landed a Big Deal. Now it Could Have a Big Fight. -- WSJ

DJ

Lezen

5 dec 2025, 19:44 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

5 dec 2025, 19:44 UTC

Marktinformatie

Canada Dollar Gains Nearly 1% on Jobs Data, Rate Outlook -- Market Talk

DJ

Lezen

5 dec 2025, 19:39 UTC

Marktinformatie

Silver Climbs to a New Record High -- Market Talk

DJ

Lezen

5 dec 2025, 19:31 UTC

Acquisities, Fusies, Overnames

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

DJ

Lezen

5 dec 2025, 18:30 UTC

Marktinformatie

Canada Jobless Rate Can Fall More Before Labor Slack Disappears -- Market Talk

DJ

Lezen

5 dec 2025, 18:28 UTC

Acquisities, Fusies, Overnames

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

DJ

Lezen

5 dec 2025, 18:24 UTC

Acquisities, Fusies, Overnames

AMC and IMAX Stocks Drop. Roku Rises. How the Netflix-Warner Bros. Deal Could Shake Up Entertainment. -- Barrons.com

DJ

Lezen

5 dec 2025, 18:20 UTC

Marktinformatie

Baker Hughes Reports Higher U.S. Rig Count -- Market Talk

DJ

Lezen

5 dec 2025, 18:11 UTC

Marktinformatie

The Tale of Two Canadian Employment Indicators -- Market Talk

DJ

Lezen

5 dec 2025, 17:48 UTC

Marktinformatie

Canadian Youth Unemployment Rate Cools -- Market Talk

DJ

Lezen

5 dec 2025, 17:44 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

MiNK Therapeutics Prognose

Koersdoel

By TipRanks

204.35% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 35 USD  204.35%

Hoogste 35 USD

Laagste 35 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor MiNK Therapeutics - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan MiNK Therapeutics - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

7.81 / 8.1Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Lange Termijn

Bearish Evidence

There is one bearish event.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,008.98

↓-0.15%

JNJ

Johnson and Johnson

201.79

↓-0.2%

ABBV

AbbVie Inc

226.23

↓-1.07%

UNH

UnitedHealth Group Inc

330.51

↓-0.85%

AZN

AstraZeneca PLC ADR

90.18

↑ +0.23%
help-icon Live chat